MedTrace Logo

Metabolic Syndrome in Childhood Cancer Survivors

NCT03773718 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2018-12-20

No results posted yet for this study

Summary

The research is devoted to studying the features of the metabolic syndrome in cancer survivors in childhood is supposed to answer the following questions:

* How can metabolic syndrome be diagnosed in the Russian population of survivors of acute lymphoblastic leukemia and non-Hodgkin's lymphomas?
* What are the features of the clinical symptoms of metabolic syndrome in this category of patients?
* Which genetic mutations are found in cancer survivors of patients with metabolic syndrome; Which of these mutations can be considered as protective or vice versa predisposing to the development of metabolic syndromes? Is the metabolic syndrome associated with an increased frequency of toxic complications of therapy during the intensive stages?

Conditions

  • Metabolic Syndrome

Sponsors & Collaborators

  • Federal Research Institute of Pediatric Hematology, Oncology and Immunology

    lead OTHER

Principal Investigators

  • Melissa M. Hudson, MD · St. Jude Children's Research Hospital Memphis, TN 38105

Eligibility

Min Age
5 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-20
Primary Completion
2021-09-20
Completion
2022-12-20

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03773718 on ClinicalTrials.gov